Employment of Alginate Floating <i>In Situ</i> Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies

<div>Particle size distribution curve by the intensity of CXB in PEG 600 80% <span class="nowrap"><svg height="11.439pt" id="M80" style="vertical-align:-2.15067pt" version="1.1" viewbox="-0.0498162 -9.28833 17.2457 11.439" width="17.2457pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M219 86C216 168 211 250 206 337C201 410 189 448 163 448C131 448 79 396 43 344L60 322C91 359 110 375 118 375S132 358 136 298C141 238 152 81 155 -12H182C242 62 331 177 390 258C435 321 451 360 451 391C450 424 432 448 408 448C390 448 372 435 366 419C362 410 362 401 366 394C373 383 376 367 376 350C376 283 262 138 221 86H219Z"></path></g><g transform="matrix(.013,0,0,-0.013,5.863,0)"><path d="M368 703H309L44 -163H104L368 703Z"></path></g><g transform="matrix(.013,0,0,-0.013,11.224,0)"><path d="M219 86C216 168 211 250 206 337C201 410 189 448 163 448C131 448 79 396 43 344L60 322C91 359 110 375 118 375S132 358 136 298C141 238 152 81 155 -12H182C242 62 331 177 390 258C435 321 451 360 451 391C450 424 432 448 408 448C390 448 372 435 366 419C362 410 362 401 366 394C373 383 376 367 376 350C376 283 262 138 221 86H219Z"></path></g></svg>.</span></div>

BioMed Research International

fig4

Figure 4

Figure 4: Employment of Alginate Floating <i>In Situ</i> Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies 

BioMed Research International

Employment of Alginate Floating In Situ Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies

Figure 4